Velocity Clinical Research

Dallas, Texas 75230

1 studies enrolling now · 10 studies all time

What they study most

Obese But Otherwise Healthy Participants, Obesity, Obesity or Overweight, Steatohepatitis, Nonalcoholic, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 2 Diabetes Treated With Insulin

Studies at this site

• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Recruiting now
• A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity — Completed
• A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes — Running, not enrolling
• A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity — Running, not enrolling
• Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions — Completed
• Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus — Stopped early
• In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes — Completed
• Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D) — Completed
• A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities — Completed
• A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224 — Completed